Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.38) per share. This is a 20.83 percent increase over losses of $(0.48) per share from the same period last year.
Barclays Maintains Overweight on Couchbase, Raises Price Target to $54
Barclays analyst Raimo Lenschow maintains Couchbase (NASDAQ:BASE) with a Overweight and raises the price target from $42 to $54.
